Bone health and hormonal contraception

Monica Dragoman, Andrew M. Kaunitz, Michael R. McClung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hormonal contraception, including progestin-only and combined estrogen and progestin methods, represent the majority of commonly used, effective, reversible contraceptives available. However, observed changes in bone mineral density (BMD) among users of these methods have prompted concerns about skeletal health. This chapter aims to review current knowledge about the association between hormonal contraception and bone density, and the observed or possible consequences of those changes resulting from exposure at various time points across the life cycle. In addition, the hypoestrogenic effects of lactation will be considered in this discussion. Most of the chapter focuses on the impact of hormonal contraceptive use on bone health in healthy women and adolescents. In addition, consideration will also be given to the use of hormonal contraception in women at elevated risk for impaired bone health.

Original languageEnglish (US)
Title of host publicationContraception for the Medically Challenging Patient
PublisherSpringer New York
Pages287-306
Number of pages20
ISBN (Electronic)9781493912339
ISBN (Print)9781493912322
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Health Professions(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Bone health and hormonal contraception'. Together they form a unique fingerprint.

  • Cite this

    Dragoman, M., Kaunitz, A. M., & McClung, M. R. (2014). Bone health and hormonal contraception. In Contraception for the Medically Challenging Patient (pp. 287-306). Springer New York. https://doi.org/10.1007/978-1-4939-1233-9_16